|Filed Under:||Medical / Healthcare IT|
|Posts on Regator:||261|
|Posts / Week:||0.9|
|Archived Since:||April 6, 2010|
Three big takeaways from HIMSS14 were: It was great to meet so many new people. Found lots of fodder for future work. I was expecting more push back on my EHR 2.0 trends. The best thing about an event like … Continue reading ?
What an epic (or is it Epic, or for that matter EPIC) ride where one seemingly goes in and out of noise tunnels on the exhibit floor all in the hopes of finding some meaningful signal as to what is … Continue reading ?
Next week is that proverbial event we all, in the HIT industry, look forward to with some trepidation - HIMSS’14. For an analyst firm such as ours HIMSS provides us a great opportunity to talk with end users, vendors of all … Continue reading ?
(Super Health Information Technology) I’ve had the good fortune of working with John and the Chilmark Research team in some capacity since 2011. As expected, I’ve learned a lot about the field, the technology, the policy, and so on and … Continue reading ?
If you see me in flip flop sandals, Vibram Five Fingers (VFF), or a barefoot-style shoe at HIMSS14 — please withhold fashion judgment. Since Jan 1, 2014, I have been performing a little “care management” on myself — as ordered … Continue reading ?
Readers that have been with us for a few years may recall that February is a very special month for our family. It is our Founder and Managing Director, John Moore Jr’s birthday on the 11th, my birthday on the 15th, … Continue readi...
Under HITECH, physicians and hospitals have adopted EHR technology in droves but are now coming to grips with the fact that their brand new EHR is not well-suited for the new world of value-based reimbursement (VBR). For years, healthcare providers … Continue reading ?
Payers focus consumer tech initiatives on engagement, ROI FierceHealthIT January 22, 2014
For many, the delay of Stage 3 of the Meaningful Use program evoked a collective sigh of relief, providing a much-needed extra year to focus on the challenging requirements for patient engagement and interoperability. As distant as 2017 may seem … Continue reading ?
What a difference a year has made to the payer market. In late 2012 Chilmark Research published the first version of our Payer Benchmark report — detailing how leading payers were beginning to adopt emerging consumer technologies. We found a market … Continue reading ?
That time of year once again where we collectively look into our crystal ball, or throw the sticks or maybe even look at the coffee grinds dripping down the sides on our coffee cup to see what may be in … Continue reading ?
Last week I attended the annual Data Warehousing (TDWI) event in Orlando. This is a fantastic, intimate setting of the top experts, and plenty of novices, in data warehousing and analytics. The event is totally focused on education, with only … Continue reading ?
Another year, another mHealth Summit. HIMSS’ younger sibling has slowly grown over the last five years, a period that has seen a Precambrian explosion of companies and advances in mobile tech. However, despite some early hints of maturity, the mHealth … Continue reading ?
As we head into the New Year, we at Chilmark Research have been thinking a lot about how we will approach Population Health Management (PHM) in 2014, and beyond. PHM is actually a pretty unfortunate term for the data-driven business … Continue reading ?
Our ongoing coverage of the HIE industry leads us to the question of what clinicians do after getting connected to an HIE? To this end, we are conducting a 10-minute web survey on clinician’s experiences using HIEs for care coordination. … Continue reading ?
As most of our readers are likely aware, the FDA this week issued a scathing letter effectively prohibiting the 5 year-old, 23andMe personal genomics testing company from doing business. Quite frankly, this is all pretty unnecessary, and reflects poor policy … Continue reading ?
A common and somewhat unique aspect to EHR vendor contracts is that the EHR vendor lays claim to the data entered into their system. Rob and I, who co-authored this post have worked in many industries as analysts. Nowhere, in … Continue reading ?
Certainly Wall St. sees value in Twitter with its share price sky-rocketing on first day of trading, but is there truly value in Twitter for us out there wandering the Internet ether? Simply put: Yes With the caveat, that you … Continue reading ?
WebMD, the once-darling of consumer health who seemingly lost its way following pharma dollars, may at last be coming back to its roots. Last week, WebMD made headlines by announcing it had purchased the young patient engagement start-up, Avado, for … Continue reading ?
Having taken a hiatus from last year’s Health 2.0 event, was looking forward to this year’s event to see what may be new and upcoming among those looking to disrupt the status quo. Unfortunately, surprisingly little. Health 2.0 a couple … Continue reading ?